Tilray Brands (NASDAQ:TLRY) is a global cannabis and consumer packaged goods company. It has diversified its business beyond the competitive Canadian cannabis market through acquisitions. Key cannabis industry competitors include Green Thumb Industries, Truelive Cannabis, and Curaleaf.
On August 4, 2026, Tilray Brands' Chief Financial Officer, Merton Carl A, purchased 10,000 shares at $4.62 each. This transaction increased his total holdings in the company to 139,753 shares. This action is often seen as a sign of an executive's positive outlook on the company's future and investor confidence.
This insider confidence comes as Tilray Brands' stock has declined 57% this year, reaching new lows. This drop is part of a wider cannabis market trend, with investors awaiting details on U.S. cannabis reclassification. This includes moving marijuana to Schedule III of the Controlled Substances Act.
Despite the stock's performance, Tilray Brands reported record net revenue of $915.50 million, an 11% increase. As highlighted by Fool - Investing News, this growth is heavily driven by acquisitions. This makes it difficult to measure the company's organic growth, which is growth from its core operations. A Seeking Alpha report notes adjusted net income fell 60%. However, Tilray Brands has a low debt-to-equity ratio of 0.25 and a healthy current ratio of 2.21, showing financial stability.
